1. Home
  2. PRCH vs AVIR Comparison

PRCH vs AVIR Comparison

Compare PRCH & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

HOLD

Current Price

$9.19

Market Cap

962.0M

Sector

Technology

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$3.48

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
AVIR
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
962.0M
266.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRCH
AVIR
Price
$9.19
$3.48
Analyst Decision
Strong Buy
Hold
Analyst Count
9
1
Target Price
$17.56
$6.00
AVG Volume (30 Days)
1.5M
393.0K
Earning Date
02-24-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$442,483,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.06
N/A
P/E Ratio
$34.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.72
$2.46
52 Week High
$19.44
$4.02

Technical Indicators

Market Signals
Indicator
PRCH
AVIR
Relative Strength Index (RSI) 41.18 58.89
Support Level $8.86 $3.29
Resistance Level $9.75 $3.63
Average True Range (ATR) 0.36 0.14
MACD 0.13 0.00
Stochastic Oscillator 34.57 63.41

Price Performance

Historical Comparison
PRCH
AVIR

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: